| A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C. | 21520194 | PMC3144992 | Journal | 2011 | 10.1002/hep.24370 | HALT-C | | Contributing Study |
| Biomarkers of active fibrogenesis and immune cell activity are each predictors of specific liver-related outcomes in patients with chronic hepatitis C | | | Conference Presentation | 2024 | | HALT-C | 23096 | Secondary Research |
| Bleeding After Elective Interventional Endoscopic Procedures in a Large Cohort of Patients With Cirrhosis | 33337822 | PMC7748214 | Journal | 2020 | 10.14309/ctg.0000000000000288 | HALT-C | 20643 | Secondary Research |
| Comparison of approaches for incorporating new information into existing risk prediction models. | 27943382 | | Journal | 2017 | 10.1002/sim.7190 | HALT-C, Virahep-C | 10835 | Secondary Research |
| Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. | 26186989 | PMC4615534 | Journal | 2015 | 10.1016/j.jhep.2015.06.035 | Virahep-C, HALT-C | 10835 | Secondary Research |
| Fibroblast activity kills - Circulating endotrophin (PRO-C6) is prognostic for liver-related events in cirrhotic patients with chronic hepatitis C | | | Conference Presentation | 2024 | | HALT-C | 23096 | Secondary Research |
| Generic chemoprevention of hepatocellular carcinoma | 30221358 | PMC6420365 | Journal | 2018 | 10.1111/nyas.13971 | HALT-C | 20830 | Secondary Research |
| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 | 33634751 | PMC7996087 | Journal | 2021 | 10.1080/15548627.2020.1797280 | HALT-C | 20830, 21551 | Secondary Research |
| Impact of HCV core gene quasispecies on hepatocellular carcinoma risk among HALT-C trial patients. | 27246310 | PMC4887904 | Journal | 2016 | 10.1038/srep27025 | HALT-C | 20973 | Secondary Research |
| Increased sialylation of site specific O-glycoforms of hemopexin in liver disease. | 27688741 | PMC5034550 | Journal | 2016 | 10.1186/s12014-016-9125-x | HALT-C | 20623 | Secondary Research |
| Molecular classification of hepatocellular carcinoma: potential therapeutic implications | 26617981 | PMC4662420 | Journal | 2015 | 10.2217/hep.15.26 | HALT-C | 20830 | Secondary Research |
| Molecular prognostic prediction in liver cirrhosis | 26420954 | PMC4579874 | Journal | 2015 | 10.3748/wjg.v21.i36.10262 | HALT-C | 20830 | Secondary Research |
| PR0-C3 determined active fibrogenesis is a predictor of liver-related outcomes in patients with chronic hepatitis C | | | Conference Presentation | 2024 | | HALT-C | 23096 | Secondary Research |
| Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. | 19052125 | PMC2606037 | Journal | 2008 | 10.1056/NEJMoa0707615 | HALT-C | | Contributing Study |
| Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials. | 27375287 | PMC5841614 | Journal | 2016 | 10.1093/ije/dyw118 | SISTEr, DPP, FAVORIT, HEMO, MTOPS, ATN, HALT-C | 6371, 6372, 6830, 8068, 8148, 8168, 8169, 8170 | Secondary Research |
| Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine | 28989095 | PMC5818315 | Journal | 2017 | 10.1016/j.jhep.2017.09.016 | HALT-C | 20830 | Secondary Research |
| Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection. | 26541123 | | Journal | 2016 | 10.1017/S0007114515004158 | HALT-C | 1608 | Secondary Research |
| Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C. | 25135867 | PMC4272642 | Journal | 2015 | 10.1016/j.jhep.2014.08.013 | HALT-C | 7988 | Secondary Research |
| Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated? | 28337405 | PMC5358664 | Journal | 2017 | 10.1007/s11901-017-0336-z | HALT-C | 20830 | Secondary Research |
| WHO guidelines for Prevention, Care and Treatment of Individuals Infected with HBV: A US Perspective | 31266617 | PMC9616205 | Journal | 2022 | 10.1016/j.cld.2019.04.008 | HALT-C | 21280 | Secondary Research |
